Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Large-scale phase III trial assesses ChimeriVax-Dengue vaccine in Singapore

Dec. 22, 2011

Novel engineered physiocrine has thrombopoietic effects in vivo

Dec. 22, 2011

U.K. study describes distribution of transient receptor potential TRPA1 channel in human lung

Dec. 22, 2011

Novel glucocorticoid receptor agonist shows anti-inflammatory activity

Dec. 21, 2011

Dual dopamine D2 receptor/NET inhibitors identified by Astellas Pharma

Dec. 21, 2011

Malaria vaccine is safe and immunogenic in phase Ib study

Dec. 21, 2011

Scientists at AstraZeneca present new therapy for AML

Dec. 21, 2011

Putative biomarker in non-cystic fibrosis bronchiectasis identified

Dec. 21, 2011

Novel biomarker for B-cell lymphoma discovered in Japan

Dec. 20, 2011

New inhibitor of cyclin-dependent kinase 9 shows preclinical potential in CLL

Dec. 20, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...